Condition
Fibrosis, Liver clinical trials and research
As of November 12, 2026, Find a Trial lists 8 Fibrosis, Liver clinical trials that are recruiting, at sites in 17 countries (most in Belgium (3), Italy (3), United States (2)). By phase: Phase 1/2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 8Clinical trials
- 17Countries
Newest Fibrosis, Liver clinical trials
All recruiting trials (8)
-
Bile acid and gut microbiota changes in people with hepatitis D starting bulevirtide
This project will see if starting bulevirtide changes bile acids and gut bacteria in adults with chronic hepatitis D who are already on hepatitis B therapy.
-
Examining Non-Alcoholic Fatty Liver Disease in Patients with Inflammatory Bowel Disease
This study looks at how common Non-Alcoholic Fatty Liver Disease is in people with Inflammatory Bowel Disease to see how gut health might affect liver health.
-
Endoscopic ultrasound shear wave elastography for measuring liver fibrosis
This study will test whether endoscopic ultrasound shear wave elastography and attenuation imaging can estimate liver fibrosis compared with biopsy and FibroScan in adults with suspected MASLD or MASH.
-
Using sulfasalazine to treat liver fibrosis and cirrhosis.
This study is testing if the medication sulfasalazine can help improve liver function and health in people with different types of cirrhosis.
-
Evaluating liver disease screening for individuals with alcohol use disorder
This study tests if screening for liver disease with a special measurement helps people in alcohol treatment stay sober or drink less over six months.
-
Effects of coffee on gut microbiome and liver health in colorectal cancer patients
This study is testing whether drinking 6 grams of freeze-dried instant coffee daily can improve liver health and gut bacteria in people who have finished treatment for colorectal cancer.
-
Screening patients at risk for liver disease in Europe
This study is trying to find out if screening high-risk patients in Europe for liver disease using simple tests can help doctors identify and better understand conditions like metabolic dysfunction-associated steatotic liver disease.
-
A registry for studying Non-Alcoholic Fatty Liver Disease in Europe
This study is collecting health information and samples from people with Non-Alcoholic Fatty Liver Disease to learn more about the disease and find better ways to track its progress.
Related topics
Quick answers
How many Fibrosis, Liver clinical trials are recruiting right now?
8, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 17 countries. The most sites are in Belgium (3 trials), Italy (3 trials), United States (2 trials), France (2 trials), Germany (2 trials). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1/2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.